ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028

 

 

TABLE OF CONTENTS

1. ASIA-PACIFIC  CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET

2.2. KEY INSIGHTS

2.2.1. KEY PLAYERS’ PROMISING COLLABORATIONS

2.2.2. INCREASE IN SCREENING TESTS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. KEY BUYING IMPACT ANALYSIS

2.4.1. PERFORMANCE

2.4.2. EASE OF USE

2.4.3. SECURITY

2.4.4. COST EFFECTIVENESS

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. INDUSTRY COMPONENTS

2.8. REGULATORY FRAMEWORK

2.9. KEY MARKET STRATEGIES

2.9.1. ACQUISITIONS

2.9.2. PRODUCT LAUNCHES

2.9.3. CONTRACTS & AGREEMENTS

2.9.4. INVESTMENTS & EXPANSIONS

2.10. MARKET DRIVERS

2.10.1. NEED TO OVERCOME THE BARRIERS IN CLINICAL TRIALS

2.10.2. RISE IN TRIALS DUE TO INCREASED DISEASE INCIDENCE

2.11. MARKET CHALLENGES

2.11.1. DELAYED APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK

2.11.2. USE OF OPEN-SOURCE SOFTWARE

2.12. MARKET OPPORTUNITIES

2.12.1. INCREASING DEMAND FOR VACCINES AND PHARMACEUTICALS

2.12.2. DATA MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH

2.12.3. ACQUISITIONS IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET

3. ASIA-PACIFIC  CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE

3.1. PHASE I

3.2. PHASE II

3.3. PHASE III

3.4. PHASE IV

4. ASIA-PACIFIC  CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE

4.1. CLINICAL TRIAL SITE MANAGEMENT

4.2. ADMINISTRATIVE SERVICES

4.3. PATIENT RECRUITMENT MANAGEMENT

4.4. REGULATORY SERVICES

4.5. DATA MANAGEMENT

4.6. OTHER SERVICES

5. ASIA-PACIFIC  CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR

5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES

5.2. MEDICAL DEVICE COMPANIES

5.3. OTHER SPONSORS

6. ASIA-PACIFIC  CLINICAL TRIALS SUPPORT SERVICES MARKET – COUNTRY OUTLOOK

6.1. CHINA

6.2. JAPAN

6.3. INDIA

6.4. SOUTH KOREA

6.5. ASEAN COUNTRIES

6.6. AUSTRALIA & NEW ZEALAND

6.7. REST OF ASIA-PACIFIC

7. COMPETITIVE LANDSCAPE

7.1. IQVIA

7.2. PAREXEL

7.3. ICON PLC

7.4. SYNEOS HEALTH

7.5. LABCORP DRUG DEVELOPMENT

7.6. CLINIPACE

7.7. KCR

7.8. CHARLES RIVER LABORATORIES

7.9. MEDPACE

7.10. ALCURA

7.11. PSI CRO

7.12. WORLDWIDE CLINICAL TRIALS

7.13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC

7.14. WUXI APPTEC

7.15. ADVANCED CLINICAL

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

 

TABLE LIST

TABLE 1: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 2: LIST OF COLLABORATIONS

TABLE 3: VENDOR SCORECARD

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: LIST OF ACQUISITIONS

TABLE 6: LIST OF PRODUCT LAUNCHES

TABLE 7: LIST OF CONTRACTS & AGREEMENTS

TABLE 8: LIST OF INVESTMENTS & BUSINESS EXPANSIONS

TABLE 9: LIST OF PANDEMIC OUTBREAKS

TABLE 10: LIST OF OPEN-SOURCE SOFTWARE

TABLE 11: LAUNCH OF MEDICAL DRUGS

TABLE 12: PROMISING ACQUISITIONS IN THE MARKET

TABLE 13: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)

TABLE 14: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 15: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)

TABLE 16: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

 

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS

FIGURE 2: MARKET ATTRACTIVENESS INDEX

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 & 2028 (IN %)

FIGURE 5: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)

FIGURE 6: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028 (IN %)

FIGURE 10: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028 (IN %)

FIGURE 17: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 21: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 22: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 23: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 24: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 25: ASEAN COUNTRIES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 26: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 27: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

 

 

Rise in the number of domestic CROs supports the market growth in the Asia-Pacific.

 

MARKET OUTLOOK

A report by Triton Market Research depicts that the market for clinical trials support services in the Asia-Pacific would advance with a CAGR of 8.41% over the projected phase from 2022 to 2028. Japan, ASEAN countries, India, Australia & New Zealand, China, South Korea, and Rest of Asia-Pacific are scrutinized in the market in this region.

Japan has developed its infrastructure for clinical trials. Now, several major pharmaceutical companies or CROs are increasingly choosing it as a preferred location to conduct clinical trials. This is because the regulatory frameworks in the country now align with the timelines of drug approval in the US and Europe. Apart from leading multinationals, domestic players are also offering support services for conducting clinical trials in Japan. With the improvement in the regulatory guidelines, the bar for conducting clinical trials in Japan has risen. These developments indicate an overall positive outlook for the Japanese market.

 

Get more insights into the Asia-Pacific Clinical Trials Support Services Market:

 

https://www.tritonmarketresearch.com/reports/asia-pacific-clinical-trials-support-services-market

 

Even in India, there are a number of domestic contract research organizations (CROs) that offer support services for clinical trials. For instance, Abiogenesis Clinpharm is a leading name in the field of support services for clinical trials of drugs, nutraceuticals, vaccines, medical devices, biosimilars, and herbal products. It offers services such as clinical operations, biostatistics, data management, site management services, and so forth. Another company, Accutest Research Laboratories, is a global independent and internationally accredited CRO. It offers bioanalytical services, assistance for seeking regulatory approvals, and customized studies for challenging drugs that require complex designs, while also ensuring special attention to safety parameters. Thus, the presence of dedicated domestic players is strengthening the growth of the Indian market.

 

COMPETITIVE OUTLOOK

The notable companies in the clinical trials support services market are Syneos Health, CTI Clinical Trial and Consulting Services Inc, WuXi AppTec, ICON Plc, Charles River Laboratories, Parexel, PSI CRO, and Clinipace.

 

SEGMENTATION

1. IQVIA

2. PAREXEL

3. ICON PLC

4. SYNEOS HEALTH

5. LABCORP DRUG DEVELOPMENT

6. CLINIPACE

7. KCR

8. CHARLES RIVER LABORATORIES

9. MEDPACE

10. ALCURA

11. PSI CRO

12. WORLDWIDE CLINICAL TRIALS

13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC

14. WUXI APPTEC

15. ADVANCED CLINICAL